<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:chebi fb="0" ids="16469">17beta-estradiol</z:chebi> (E2) replacement therapy in ovariectomized (OVX) female rats reduces leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and brain damage after transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, we found that E2 treatment in diabetic OVX females was associated with enhanced postischemic neuropathology </plain></SENT>
<SENT sid="2" pm="."><plain>We tested the hypothesis that in chronically hyperglycemic diabetic OVX females, <z:hpo ids='HP_0011010'>chronic</z:hpo> E2 replacement potentiates post-transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Pial venules were observed through closed cranial windows </plain></SENT>
<SENT sid="4" pm="."><plain>Adherence of <z:chebi fb="0" ids="52672">rhodamine 6G</z:chebi>-tagged leukocytes was monitored before and 10 hours after transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (20 minutes right common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> plus hemorrhagic <z:hpo ids='HP_0002615'>hypotension</z:hpo>) in intact, untreated OVX and E2-treated OVX females rendered diabetic via <z:chebi fb="1" ids="9288">streptozotocin</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> was quantitated as the percentage venular area occupied by adherent leukocytes </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: At 2 hours after transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, a similar low level of leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> was seen in the 3 groups (&lt;3% of the venular area) </plain></SENT>
<SENT sid="7" pm="."><plain>Starting at approximately 4 hours after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> in the E2-treated OVX females rose to significantly higher levels compared with the other groups </plain></SENT>
<SENT sid="8" pm="."><plain>Relative to the 2-hour value, the level of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> at 10 hours was 12.5-fold, 4-fold, and 5-fold greater in the E2-treated OVX, OVX, and intact groups, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>Leukocyte extravasation (beginning after 6 hours of reperfusion) was observed in a majority (64%) of the E2-treated animals, with limited or no extravasation seen in the intact or OVX groups </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: These results suggest that factors associated with <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> convert E2 from a counterinflammatory to a proinflammatory substance in an ischemic setting </plain></SENT>
</text></document>